✦ LIBER ✦

20LBA A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma

✍ Scribed by D. Henry; R. von Moos; S. Vadhan-Raj; V. Hungria; A. Spencer; V. Hirsh; J. Wang; S. Jun; H. Yeh; R. Dansey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2LBA Denosumab versus zoledronic acid fo

✍ A. Stopeck; J.J. Body; Y. Fujiwara; A. Lipton; G.G. Steger; M. Viniegra; M. Fan; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Pain outcomes in patients with advanced

✍ Charles S. Cleeland; Jean-Jacques Body; Alison Stopeck; Roger von Moos; Lesley F 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Denosumab versus zoledronic acid for tre

✍ Karim Fizazi; Michael Carducci; Matthew Smith; Ronaldo Damião; Janet Brown; Lawr 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 840 KB

Re: Denosumab Versus Zoledronic Acid for

✍ Walsh, Patrick C. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 110 KB

Results of a prospective, randomized, do

✍ Jean-Jacques Body; Alison Stopeck; Yasuhiro Fujiwara; Allan Lipton; Guenther Ste 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Results From a Phase 3 Randomized, Doubl

✍ Roger von Moos; David Henry; Saroj Vadhan-Raj; Vania Hungria; Andrew Spencer; Ve 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB